As of 2025-07-16, the Intrinsic Value of Quest Diagnostics Inc (DGX) is 204.38 USD. This DGX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 167.03 USD, the upside of Quest Diagnostics Inc is 22.40%.
The range of the Intrinsic Value is 160.09 - 274.65 USD
Based on its market price of 167.03 USD and our intrinsic valuation, Quest Diagnostics Inc (DGX) is undervalued by 22.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 160.09 - 274.65 | 204.38 | 22.4% |
| DCF (Growth 10y) | 212.49 - 348.65 | 265.32 | 58.8% |
| DCF (EBITDA 5y) | 179.58 - 250.23 | 222.19 | 33.0% |
| DCF (EBITDA 10y) | 225.79 - 315.54 | 276.17 | 65.3% |
| Fair Value | 73.73 - 73.73 | 73.73 | -55.86% |
| P/E | 196.85 - 250.36 | 211.99 | 26.9% |
| EV/EBITDA | 125.58 - 185.03 | 166.51 | -0.3% |
| EPV | 93.00 - 131.77 | 112.38 | -32.7% |
| DDM - Stable | 68.51 - 135.60 | 102.05 | -38.9% |
| DDM - Multi | 136.32 - 209.22 | 165.03 | -1.2% |
| Market Cap (mil) | 18,647.23 |
| Beta | 0.24 |
| Outstanding shares (mil) | 111.64 |
| Enterprise Value (mil) | 24,318.23 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.77% |
| Cost of Debt | 4.57% |
| WACC | 6.70% |